Writing a WHO-aligned TB laboratory waste procedure

A clear TB laboratory waste segregation and disposal procedure turns broad safety expectations into actions staff can follow during a busy shift. It should explain how to identify, separate, contain, decontaminate, move and document waste generated by sputum microscopy, culture, molecular testing and related support activities.

The procedure needs to reflect WHO principles for infection prevention, laboratory biosafety and healthcare waste management, while also fitting the laboratory’s actual equipment, staffing, transport arrangements and disposal contracts. A small regional service in the Northern Territory may need a different workflow from a large metropolitan laboratory in Melbourne or Sydney.

Australian laboratories must also account for state and territory environmental and workplace laws. Clinical waste rules, transport requirements and approved treatment options can vary between New South Wales, Queensland, Victoria, Western Australia and other jurisdictions. The written procedure should therefore point staff to the applicable local regulator and the laboratory’s licensed waste contractor.

A useful document is specific enough to prevent guesswork but practical enough for routine use. Staff should know which container to use at the bench, what to do when a specimen leaks, who authorises collection, and how the laboratory verifies that infectious waste has been made safe before final disposal.

Define the scope and risk categories

Begin with the purpose of the procedure and identify every area it covers. This may include specimen reception, sputum processing, microscopy, nucleic acid amplification testing, culture, antimicrobial susceptibility testing, cleaning, equipment maintenance and temporary waste storage. State clearly that material contaminated or potentially contaminated with Mycobacterium tuberculosis is treated as infectious unless a documented risk assessment says otherwise.

The procedure should distinguish waste streams rather than using a single “biohazard” category. Common streams include infectious solid waste, contaminated sharps, liquid biological waste, chemical waste, pharmaceutical or cytotoxic waste where relevant, and ordinary general waste. Used culture media, tubes, pipette tips, swabs and disposable gowns generally require infectious waste controls. Needles, broken slides and contaminated blades require puncture-resistant sharps containers.

Include a short risk statement explaining that aerosol-generating activities, spills, centrifugation and handling of cultures require particular care. TB waste may contain viable organisms even when the patient has started treatment. The procedure should align with the laboratory’s risk assessment, containment level, biosafety manual and relevant WHO laboratory guidance rather than relying on assumptions about the test method.

Set segregation rules at the point of use

Segregation works best when the correct containers are positioned beside the activity that creates the waste. Use leak-resistant, closable containers for infectious material and rigid, puncture-resistant containers for sharps. Containers should display the biohazard symbol, identify their contents and show the fill limit. A foot-operated lid or hands-free opening can reduce contact with contaminated surfaces.

Write simple instructions for what belongs in each container. Do not place clean packaging into clinical waste, and do not put contaminated items into general rubbish merely because they appear dry. Used slides, contaminated disposable plastics and materials from specimen processing should go into the designated infectious stream. Sharps must never be bent, broken, recapped or pushed down by hand.

Where colour coding is used, describe the local scheme in words as well as colours. Colour conventions can differ between facilities and suppliers, while lighting and fading can make colours unreliable. Australian laboratories should check that bins and bags meet the requirements of their state or territory and are accepted by the contracted clinical waste provider, particularly when services are collected from remote sites.

Describe safe containment and internal transport

The procedure should explain how staff close, label and replace containers. Bags must not be overfilled, and staff should seal them before removal from the work area. Leaking bags should be placed into a second compatible container without compressing the contents. Labels may include the waste type, source laboratory, date, responsible person and any special hazard such as chemical contamination.

Internal transport should use a dedicated, cleanable trolley or secondary container. The route should avoid public areas, food preparation spaces and patient waiting rooms. Specify how often waste is removed, where it is held temporarily and who checks that the storage area is secure, ventilated, pest-resistant and inaccessible to unauthorised people.

A specimen courier route across regional Queensland or a long haul from a bush laboratory to a larger centre may require a different contingency plan from an inner-city service. Document maximum holding times, temperature or weather considerations, missed collections and emergency contacts. Staff should never leave infectious waste beside a public bin, loading dock or roadside collection point while waiting for a contractor.

Choose and verify treatment and disposal methods

State how each waste category becomes safe before final disposal. Autoclaving is commonly used for suitable infectious laboratory waste, but the procedure must specify the validated cycle, load configuration, packaging, operator responsibilities and release criteria. Biological or chemical indicators, physical cycle records and routine maintenance provide evidence that the process is working.

Not every item is suitable for autoclaving. Some plastics deform, sealed containers can rupture, and chemical residues may create additional hazards. Chemical disinfection may be appropriate for selected liquid waste when the disinfectant, concentration, contact time, temperature and organic load have been validated. Never combine disinfectants or pour untreated TB cultures into a sink.

After treatment, waste may still require a controlled disposal route. Sharps usually remain a sharps hazard even when decontaminated, and autoclaved materials may need to be identified as treated clinical waste. Incineration, approved high-temperature treatment or licensed waste processing may be required under local arrangements. Keep contractor licences, manifests and treatment certificates where applicable, and confirm that the method meets Australian state or territory requirements.

Assign responsibilities, training and incident controls

A strong procedure names the people who make the system work. The laboratory manager should approve the procedure and resources, the quality manager should control the document and records, supervisors should monitor daily practice, and all workers should segregate waste correctly and report hazards. The waste contractor’s responsibilities should include collection, transport, treatment and provision of required documentation.

Training should cover waste categories, PPE, container selection, sharps safety, spill response, exposure reporting, emergency contacts and the limits of each treatment method. Include induction for new staff, refresher training and competency checks after changes to equipment or workflow. Casual, agency and courier personnel need instructions appropriate to the tasks they perform.

The spill section should be operational rather than vague. It should tell staff to restrict access, allow aerosols to settle when relevant, wear the specified PPE, use the approved disinfectant and contact the supervisor. Broken containers, centrifuge incidents, needlestick injuries and exposure to mucous membranes must be reported through the laboratory’s incident system and managed under occupational health arrangements.

For services operating across Australia, include local emergency numbers and escalation pathways. A remote facility may depend on the Royal Flying Doctor Service, a regional hospital or a scheduled road contractor, while a metropolitan site may have an on-site infection prevention team and a same-day hazardous waste collection. The procedure should work in both settings without assuming immediate access to specialist support.

Monitor performance and improve the procedure

Records show whether the waste system is functioning. Keep training records, autoclave cycle results, maintenance reports, spill and exposure reports, waste collection documentation, contractor checks and audit findings. A simple monthly review can track overflowing bins, incorrect segregation, missed collections, damaged containers and repeated staff questions.

Include measurable checks such as the percentage of work areas with correctly labelled containers, completion of treatment records, and the number of segregation errors identified during observation. Review incidents for underlying causes. An overflowing sharps bin may indicate poor collection scheduling, while repeated contamination of general waste may indicate confusing labels or containers located too far from the bench.

Continual improvement should connect waste management with the laboratory’s wider quality system. The Phase 4 roadmap can help laboratories incorporate monitoring, corrective action, management review and sustained improvement into their quality activities. This is particularly useful when the procedure changes after an audit, equipment upgrade, new test platform or revised state regulation.

Workload also affects waste safety. A sudden increase in sputum specimens can leave one shift with full bins and another with unused capacity. Laboratories can use guidance on workload distribution to match staffing, bench activity, treatment capacity and collection schedules. Store the approved procedure, forms and checklists in a controlled location, supported by the practical download materials.

A usable procedure should be trialled at the bench before approval. Ask staff to follow it during routine work and a simulated spill, then remove ambiguous wording, missing contacts and impractical steps. Have the laboratory manager, safety representative, quality lead and waste contractor review the final version, record its approval date and set a scheduled review interval.

Make the procedure visible where waste is generated, train every relevant worker, and audit the first weeks of use closely. A documented, locally compliant system protects staff, patients, contractors and the community while giving the TB laboratory clear evidence that waste is controlled from creation to final disposal.